Status:
SUSPENDED
The Galway Sea Swimmers Study
Lead Sponsor:
National University of Ireland, Galway, Ireland
Conditions:
Cardiovascular Diseases
Hypertension
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Cardiovascular disease (CVD) is the leading cause of death worldwide. Hypertension is a well-established risk factor for the development of CVD. Lifestyle modifications, including exercise, remain the...
Detailed Description
Consenting participants will be randomly assigned, 1:1, to either continuation of sea swimming or discontinuation of sea swimming for 4-6 weeks, stratified by the type of swimmer (those who purely imm...
Eligibility Criteria
Inclusion
- habitual swimmers (i.e., sea swimming at least 2 times/week for the past year)
- 18 years of age or older
- able to provide informed consent
Exclusion
- underlying cardiac (e.g., self-reported heart failure) or pulmonary diseases (e.g., self-reported chronic obstructive pulmonary disease)
- recent orthopedic procedures (e.g., joint replacement therapy)
- severe disabling comorbidity
- recent arm (both arms) or chest wall injury
- pregnant or breast feeding
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04290637
Start Date
October 1 2020
End Date
October 1 2021
Last Update
June 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Croi Heart and Stroke Centre
Galway, Ireland, H91 FF68